Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: Preliminary reference ranges

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue SUPPL. 5, 2012, Pages 51-53

  Mussap, Michele ^a   Puxeddu, Elisabetta ^b   Burrai, Patrizia ^b   Noto, Antonio ^b   Cibecchini, Francesco ^a   Testa, Marcella ^b   Puddu, Melania ^b   Ottonello, Giovanni ^b   Dessì, Angelica ^b   Irmesi, Roberta ^b   Gassa, Elisabetta Dalla ^b   Fanni, Claudia ^b   Fanos, Vassilios ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Neonatal sepsis; Preterm newborns; Reference ranges; Soluble CD14 subtype presepsin (sCD14 ST)

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; PRESEPSIN; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CHEMILUMINESCENT ENZYME IMMUNOASSAY; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CRITICAL ILLNESS; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; GESTATIONAL AGE; HUMAN; MALE; NEWBORN; NEWBORN ASSESSMENT; NEWBORN INTENSIVE CARE; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE;

ANTIGENS, CD14; FEMALE; GESTATIONAL AGE; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFLAMMATION; INTENSIVE CARE, NEONATAL; LUMINESCENT MEASUREMENTS; MALE; PROGNOSIS; REFERENCE VALUES; SEPSIS;

EID: 84866989178     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.717462     Document Type: Article

References (11)

1. Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 1991;147:1567-1574.
2. Endo S, Inada K, Kasai T, Takakuwa T, Nakae H, Kikuchi M, Yamashita H, Yoshida M. Soluble CD14 (sCD14) levels in patients with multiple organ failure (MOF). Res Commun Chem Pathol Pharmacol 1994;84:17-25.
3. Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, Takahashi G, et al. Evaluation of a newly identifed soluble CD14 subtype as a marker for sepsis. J Infect Chemother 2005;11:234-238.
4. Rey Nores JE, Bensussan A, Vita N, Stelter F, Arias MA, Jones M, Lefort S, et al. Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol 1999;29:265-276.
5. Endo S, Takahashi G, Shozushima T, Matsumoto N, Kosjika M, Suzuki Y, et al. Usefulness of presepsin (soluble CD14 Subtype) as a diagnostic marker of sepsis. JJAAM 2012;23:27-38.
6. Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta 2011;412: 2157-2161.
7. Mussap M, Noto A, Fravega M, Fanos V. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J Matern Fetal Neonatal Med 2011;24 Suppl 2:12-14.
8. Chiesa C, Natale F, Pascone R, Osborn JF, Pacifco L, Bonci E, De Curtis M. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta 2011;412:1053-1059.
9. Obata K, Segawa O, Yakabe M, Ishida Y, Kuroita T, Ikeda K, Kawakami B, et al. Development of a novel method for operating magnetic particles, Magtration Technology, and its use for automating nucleic acid purifcation. J Biosci Bioeng 2001;91:500-503.
10. CLSI. Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline. NCCLS document 2004 EP17-A.
11. Noto A, Fanos V, Puxeddu E, Irmesi R, Puddu M, Ottonello G, et al. Soluble CD14-Subtype (sCD14-ST) Presepsin In Critically Ill Preterm And Term Newborns For The Early Assessment Of Neonatal Sepsis: Preliminary Results. Accepted abstract AACC Annual Meeting, Los Angeles, July 15-19, 2012.